SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-765868
Filing Date
2016-11-10
Accepted
2016-11-10 16:03:25
Documents
52
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d268927d10q.htm 10-Q 288242
2 EX-31.1 d268927dex311.htm EX-31.1 8550
3 EX-31.2 d268927dex312.htm EX-31.2 8555
4 EX-32.1 d268927dex321.htm EX-32.1 2754
5 EX-32.2 d268927dex322.htm EX-32.2 2754
  Complete submission text file 0001193125-16-765868.txt   2061766

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pirs-20160930.xml EX-101.INS 245298
7 XBRL TAXONOMY EXTENSION SCHEMA pirs-20160930.xsd EX-101.SCH 37216
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pirs-20160930_cal.xml EX-101.CAL 40403
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pirs-20160930_def.xml EX-101.DEF 105741
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pirs-20160930_lab.xml EX-101.LAB 271810
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pirs-20160930_pre.xml EX-101.PRE 181224
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37471 | Film No.: 161987993
SIC: 8731 Services-Commercial Physical & Biological Research